TIDMAKT

RNS Number : 5202T

Ark Therapeutics Group PLC

07 December 2011

Ark Therapeutics Group plc

Director's Share Dealing

Ark Therapeutics Group plc (LSE: AKT) ("Ark" or the "Company") announces that it was informed on 6 December by Mr Peter Keen, a Non-Executive Director of Ark, that he had transferred 11,765 ordinary shares of 1p each in the Company into a Self Invested Personal Pension ("SIPP"). Accordingly, on 6 December, 11,765 ordinary shares were sold by Mr Keen at a price of 3.85 pence per share and 11,765 ordinary shares were bought by the SIPP at the price of 3.85 pence per share.

Following these transactions, there has been no change in Mr Keen's interest in the Company's ordinary shares.

For further information please contact:

 
 Ark Therapeutics Group plc            +44 (0)20 7388 7722 
 Dr Edward Bliss, Company Secretary

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBBBDDRSGBGBR

Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Premier Veterinary Charts.
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Premier Veterinary Charts.